Brochure | March 24, 2020

Asahi Oligosynthesizer™

At Asahi Kasei Bioprocess, we bring over a decade of experience to every oligosynthesizer project that we undertake, continually improving our platform as we gain valuable feedback from sponsors and contract manufacturers alike.

This wealth of knowledge allows us to understand that oligonucleotides are a rather unique breed of therapeutic – chemically synthesized, yet much larger in size than classic small molecules. Hence, our engineers employ a hybrid approach when designing manufacturing-scale equipment for oligonucleotides, blending the best of antibody equipment and small molecule equipment design principles together to generate the ideal solution specifically for your oligonucleotide.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: